White label ELPA - ClinicalTrials.eu

Study on Mosunetuzumab and Lenalidomide for Patients with Untreated Follicular Lymphoma

Recruiting

3 1 1 1
Investigated diseases:
- Follicular lymphoma
Investigated drugs:
Study on Metformin and Lifestyle Changes for Girls with Early Puberty and Overweight

Recruiting

2 1 1
Investigated diseases:
- Precocious puberty
- Overweight
Investigated drugs:
- Metformin Hydrochloride
Study of Mogamulizumab and Total Skin Electron Beam Therapy for Patients with Stage IB-IIB Cutaneous T-Cell Lymphoma

Recruiting

2 1 1 1
Investigated diseases:
Investigated drugs:
- Mogamulizumab
Study on the Use of Mesenchymal Stem Cells and Sodium Chloride for Patients with Progressive Multiple Sclerosis

Recruiting

2 1 1 1
Investigated diseases:
- Multiple sclerosis
Investigated drugs:
- Mesenchymal Stromal Cells, Ex Vivo Cultured
- Sodium Chloride
Study of INBRX-109 with Irinotecan Hydrochloride Trihydrate and Temozolomide for Patients with Advanced Solid Tumors, Including Sarcomas

Recruiting

2 1 1 1
Investigated diseases:
- Neoplasm
Investigated drugs:
Study Comparing Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone with Ciltacabtagene Autoleucel or Stem Cell Transplant for Newly Diagnosed Multiple Myeloma Patients

Recruiting

3 1 1 1
Investigated diseases:
- Plasma cell myeloma
Investigated drugs:
+3
Study of LB-100 and Atezolizumab for Patients with Metastatic Colorectal Cancer

Recruiting

1 1 1 1
Investigated diseases:
- Colorectal cancer metastatic
Investigated drugs:
- 3-(4-Methylpiperazine-1-Carbonyl)-7-Oxabiclo[2.2.1]Heptane-2-Carboxylic Acid
- Atezolizumab
Study on Baricitinib and Anti-TNF Drug Combination for Patients with Rheumatoid Arthritis

Recruiting

3 1 1
Investigated diseases:
- Rheumatoid arthritis
Investigated drugs:
Study on Cangrelor and Bivalirudin for Patients with Heart Attack-Related Cardiogenic Shock or Cardiac Arrest on VA-ECMO Support

Recruiting

2 1 1 1
Investigated diseases:
- Cardiogenic shock
Investigated drugs:
- Cangrelor Tetrasodium
Long-Term Safety Study of Iptacopan for Adults with IgA Nephropathy After Completing a Previous Study, Including ACE Inhibitors and ARBs Drug Combination

Recruiting

3 1 1 1
Investigated diseases:
- IgA nephropathy
Investigated drugs:
+7

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies